ABSTRACT
Infants and children have unique anatomic, physiologic, pharmacologic, and psychological issues relating to perioperative management. Combining this knowledge with the technical skills required for instrumentation of children is essential when contemplating anesthesia for thoracic surgery. Experience and versatility with anesthetic induction technique, airway instrumentation, vascular access and monitoring, single-lung ventilation, regional anesthesia, and postoperative pain management allow for the comprehensive management of thoracic surgical patients at any age.
Subject(s)
Anesthesia/methods , Thoracic Surgical Procedures , Adult , Analgesia/methods , Child , Humans , Infant , Infant, Newborn , Intubation, Intratracheal/methods , Mediastinal Neoplasms/surgery , Monitoring, Intraoperative/methods , Preoperative Care/methodsABSTRACT
STUDY OBJECTIVE: To compare the quality of anesthesia with propofol, ketamine, or etomidate in children undergoing brief diagnostic or therapeutic procedures. DESIGN: Retrospective study. SETTING: University hospital. PATIENTS: 971 pediatric oncology patients undergoing brief diagnostic or therapeutic procedures outside the operating room during a one-year period. INTERVENTIONS: Total intravenous anesthesia was administered primarily with ketamine, etomidate, or propofol for oncology-related procedures such as bone marrow aspiration, lumbar puncture, radiologic imaging, and radiation therapy. Quality assurance data were collected for all patients, including anesthetic technique, dosage, and the occurrence of specific adverse events during anesthesia and recovery periods. MEASUREMENTS AND MAIN RESULTS: There were 279 anesthesia-related occurrences, comprised almost entirely of five specific events: vomiting, hypoxemia (SpO2 less than 94%), tachycardia, agitation, and myoclonus. Ketamine was associated with vomiting (14.6%), agitation (15.0%), and tachycardia (19.5%). Etomidate was also associated with vomiting (9.9%) and agitation (1.2%). Hypoxemia was rare except in the propofol group (15.7%) and was easily managed with supplemental oxygen, but occasionally required manually assisted ventilation via face mask. In patients receiving propofol vomiting (0.5%) and agitation (1.2%) were rare. CONCLUSIONS: Anesthesia with propofol, ketamine, or etomidate is safe and efficacious for children undergoing brief procedures. Propofol is associated with a decreased incidence of postanesthetic agitation and vomiting. Its association with respiratory depression is confirmed.
Subject(s)
Anesthesia, Intravenous , Etomidate , Ketamine , Propofol , Adolescent , Ambulatory Surgical Procedures , Anesthesia, Intravenous/adverse effects , Child , Child, Preschool , Etomidate/adverse effects , Female , Humans , Hypoxia/chemically induced , Infant , Ketamine/adverse effects , Male , Myoclonus/chemically induced , Propofol/adverse effects , Quality Assurance, Health Care , Retrospective Studies , Tachycardia/chemically induced , Vomiting/chemically inducedABSTRACT
The multidisciplinary approach to the care of children with cancer demands an understanding of all aspects of its treatment. Recognition of potential anatomic and physiologic derangements which may result from specific types of malignancy allows optimal preoperative preparation. Understanding the anesthetic implications of cancer chemotherapy, irradiation and surgery, and the medical complications which result, is essential. The anesthesiologist is involved in critical perioperative issues during surgical resection in the operating room, but just as importantly plays a crucial role in a variety of procedures performed in remote locations. An awareness of special problems related to cancer and its treatment allows optimal anesthesia care while dealing with such issues as radical surgery, organ system failure, acute and chronic pain, and terminal illness.
Subject(s)
Anesthesia , Neoplasms/surgery , Abdominal Neoplasms/surgery , Body Temperature Regulation , Bone Marrow Transplantation , Child , Child, Preschool , Heart Function Tests , Hemodynamics , Humans , Monitoring, Intraoperative , Neoplasms/physiopathology , Pain, Postoperative/drug therapy , Premedication , Preoperative Care , Respiratory Function Tests , Respiratory Tract Neoplasms/surgery , Thoracic Neoplasms/surgeryABSTRACT
Nausea and vomiting associated with antineoplastic chemotherapy are distressing and may keep patients from complying with chemotherapy protocols. No drug has emerged among many as an effective antiemetic. It has been speculated that propofol may have intrinsic antiemetic properties. We report the use of low-dose continuous infusion propofol in three oncology patients to treat chemotherapy-associated nausea and vomiting. A bolus of 0.1 mg.kg-1 followed by a continuous infusion of 1 mg.kg-1.hr-1 was effective in both prevention and treatment of nausea and vomiting. All three patients were alert, reported low nausea scores by visual analogue scale, and had no episodes of vomiting. When the infusion was discontinued, nausea and vomiting were noted in two patients. Propofol, given in a subanaesthetic infusion, was safe and effective as an antiemetic in these three patients.
